Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection
出版年份 2020 全文链接
标题
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-12-09
DOI
10.1038/s41467-020-20139-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets
- (2020) Mathilde Richard et al. Nature Communications
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- (2020) Yixuan J. Hou et al. CELL
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- A Dynamic Immune Response Shapes COVID-19 Progression
- (2020) Eugenia Ziying Ong et al. Cell Host & Microbe
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Multiplex digital spatial profiling of proteins and RNA in fixed tissue
- (2020) Christopher R. Merritt et al. NATURE BIOTECHNOLOGY
- Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- (2020) Mingfeng Liao et al. NATURE MEDICINE
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- On the Alert for Cytokine Storm: Immunopathology in COVID ‐19
- (2020) Lauren A. Henderson et al. Arthritis & Rheumatology
- Antiviral activities of type I interferons to SARS-CoV-2 infection
- (2020) Emily Mantlo et al. ANTIVIRAL RESEARCH
- Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease
- (2020) Christoph Schultheiß et al. IMMUNITY
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
- (2020) F. La Rosée et al. LEUKEMIA
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
- (2020) Megan L. Stanifer et al. Cell Reports
- Interleukin-6 as prognosticator in patients with COVID-19
- (2020) Elisa Grifoni et al. JOURNAL OF INFECTION
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- IL-22-binding protein exacerbates influenza, bacterial super-infection
- (2019) Robert N. Abood et al. Mucosal Immunology
- Biological and pathological activities of interleukin-22
- (2016) Mirna Perusina Lanfranca et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
- (2016) Changliang Peng et al. Oncotarget
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- The Chemokine Receptor CXCR6 Controls the Functional Topography of Interleukin-22 Producing Intestinal Innate Lymphoid Cells
- (2014) Naoko Satoh-Takayama et al. IMMUNITY
- Evolution and Structural Organization of the C Proteins of Paramyxovirinae
- (2014) Michael K. Lo et al. PLoS One
- Measles Virus Nonstructural C Protein Modulates Viral RNA Polymerase Activity by Interacting with Host Protein SHCBP1
- (2013) M. Ito et al. JOURNAL OF VIROLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Interleukin-22 Is Produced by Invariant Natural Killer T Lymphocytes during Influenza A Virus Infection
- (2012) Christophe Paget et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started